GYNOL II EXTRA STRENGTH OTC
Generic Name and Formulations:
Nonoxynol-9 3% (150mg/applicatorful); contraceptive jelly; contains parabens.
Personal Products Co.
Indications for GYNOL II EXTRA STRENGTH:
1 teaspoonful spread over the surface and rim of diaphragm prior to intercourse provides 6 hrs protection. Reapply prior to each intercourse (if used with diaphragm do not remove diaphragm; use applicator). Do not remove before 6 hrs following intercourse. Extr Str may be used with condom or alone: 1 applicatorful into vagina up to 1 hr before intercourse and before each additional intercourse. For all: use with each intercourse regardless of day of menstrual cycle.
Discontinue if irritation occurs.
Local vaginal or penile irritation.
Gynol—2.5oz, 3.8oz (w. applicator)
Gynol Ext Str—2.85g (w. applicator)
Ortho-Gynol—3.8oz (w. applicator)
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally